2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow CANbridge Life Sciences Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of CAN008 in Subjects With GBM CAN008, Placebo - Newly-diagnosed Glioblastoma | Phase 2 | Unknown | CANbridge Life Sciences Ltd. | 117 | 2021-10-10 | 2022-07-12 |
| To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM) CAN008 - GBM | Phase 2 | Unknown | CANbridge Life Sciences Ltd. | 60 | 2018-11-20 | 2018-11-19 |
Glioblastoma (1)
China (1)